Spots Global Cancer Trial Database for thoracic neoplasms
Every month we try and update this database with for thoracic neoplasms cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Real World Registry for Use of the Ion Endoluminal System | NCT06004440 | Lung Cancer Multiple Pulmon... Lung Neoplasms Respiratory Tra... Thoracic Neopla... Neoplasms by Si... Neoplasms Lung Diseases Respiratory Tra... | Ion Endoluminal... | 18 Years - | Intuitive Surgical | |
| Integrated Care Pathway in Oncology (PASSION) | NCT04235556 | Colon Cancer Gastric Cancer Pancreatic Canc... Thoracic Neopla... Breast Cancer Ovarian Cancer Bladder Cancer Prostate Cancer | Care pathway un... | 18 Years - 80 Years | Assistance Publique - Hôpitaux de Paris | |
| A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) | NCT04222972 | RET-fusion Non ... Lung Neoplasm Carcinoma, Non-... Respiratory Tra... Thoracic Neopla... Neoplasms by Si... Neoplasms Lung Diseases Respiratory Tra... Carcinoma, Bron... Bronchial Disea... Head and Neck N... Adenocarcinoma Carcinoma Neoplasms by Hi... Neoplasms, Germ... Neoplasms, Nerv... | Pralsetinib Carboplatin Cisplatin Pemetrexed Pembrolizumab Gemcitabine Paclitaxel Nab-Paclitaxel | 18 Years - | Hoffmann-La Roche | |
| Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy | NCT02984761 | Lung Neoplasm | Stereotactic Ra... Anatomic Pulmon... | 18 Years - | VA Office of Research and Development | |
| Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO) | NCT04776447 | Lung Diseases Carcinoma, Non-... Stage IIIA Non-... Stage IIIB Non-... Respiratory Tra... Carcinoma Bronc... Thoracic Neopla... | Carboplatin Placlitaxel Atezolizumab | 18 Years - 75 Years | Fundación GECP | |
| Thoracic OncoGeriatric Assessment (TOGA) Trials | NCT00591981 | Thoracic Neopla... Lung Neoplasms Esophagus Neopl... Pleural Neoplas... Thymus Neoplasm... | TOGA Tools | 70 Years - | University of Wisconsin, Madison | |
| A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC | NCT03134872 | Lung Neoplasms Carcinoma, Non-... Respiratory Tra... Thoracic Neopla... Lung Diseases Respiratory Tra... Neoplasms by Si... Neoplasm, Bronc... Carcinoma, Bron... | SHR-1210 Carboplatin Pemetrexed | 18 Years - 70 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| Real World Registry for Use of the Ion Endoluminal System | NCT06004440 | Lung Cancer Multiple Pulmon... Lung Neoplasms Respiratory Tra... Thoracic Neopla... Neoplasms by Si... Neoplasms Lung Diseases Respiratory Tra... | Ion Endoluminal... | 18 Years - | Intuitive Surgical | |
| A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements | NCT03093116 | Locally Advance... Metastatic Soli... | Oral repotrecti... | 12 Years - | Turning Point Therapeutics, Inc. | |
| Neoadjuvant Aliya™ PEF Soft Tissue Ablation With Systemic Therapy in Early-Stage Resectable NSCLC | NCT05583188 | NSCLC | Aliya Pulsed El... Nivolumab plus ... Standard of car... Surgical Resect... | 18 Years - | Galvanize Therapeutics, Inc. | |
| Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC | NCT03389256 | Lung Diseases Neoplasms Respiratory Tra... Thoracic Neopla... Non-Small-Cell ... | Apatinib EGFR-TKI | 18 Years - 75 Years | Sichuan Cancer Hospital and Research Institute | |
| A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC | NCT03134872 | Lung Neoplasms Carcinoma, Non-... Respiratory Tra... Thoracic Neopla... Lung Diseases Respiratory Tra... Neoplasms by Si... Neoplasm, Bronc... Carcinoma, Bron... | SHR-1210 Carboplatin Pemetrexed | 18 Years - 70 Years | Jiangsu HengRui Medicine Co., Ltd. | |
| Monitoring Radiobiological Effects in Thoracic Malignancy by Using Myocardial Perfusion Scan | NCT01913769 | Thoracic Neopla... Late Effect of ... | Thallium-201 My... | 20 Years - 80 Years | Far Eastern Memorial Hospital | |
| Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC) | NCT01999985 | Lung Cancer Non-small Cell ... | Dasatinib - 1A Afatinib - 1A Dasatinib - 1B Afatinib - 1B | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Advanced NSCLC | NCT04959981 | Advanced Non-sq... | ERAS-007 ERAS-601 Osimertinib Sotorasib | 18 Years - 99 Years | Erasca, Inc. | |
| A Study of Napabucasin (BBI-608) Plus Weekly Paclitaxel Versus Weekly Paclitaxel Alone in Patients With Advanced, Previously Treated, Non-Squamous Non-Small Cell Lung Cancer | NCT02826161 | Carcinoma, Non-... | Napabucasin Paclitaxel | 18 Years - | Sumitomo Pharma America, Inc. | |
| Role of Ultrasound Guided Peripheral Thoracic Tumors | NCT04741958 | Thoracic Neopla... | Ultrasound Guid... | - | Beni-Suef University | |
| Improving Cancer Symptom Management | NCT04589247 | Cancer Thoracic Neopla... Gastrointestina... Lung Cancer | 18 Years - 100 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | ||
| Sintilimab (IBI308) in the Neoadjuvant Treatment of Patients With Resectable II-IIIA NSCLC | NCT04371796 | Lung Diseases Neoplasms Respiratory Tra... Thoracic Neopla... Non-small-cell ... | Sintilimab inje... | 18 Years - 75 Years | Sichuan Cancer Hospital and Research Institute | |
| A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung Cancer | NCT01039948 | Carcinoma, Non-... Lung Neoplasms Lung Cancer Respiratory Tra... | AV-299 + gefiti... Gefitinib | 18 Years - | AVEO Pharmaceuticals, Inc. | |
| A Study of Napabucasin (BBI-608) Plus Weekly Paclitaxel Versus Weekly Paclitaxel Alone in Patients With Advanced, Previously Treated, Non-Squamous Non-Small Cell Lung Cancer | NCT02826161 | Carcinoma, Non-... | Napabucasin Paclitaxel | 18 Years - | Sumitomo Pharma America, Inc. | |
| A Study of Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Advanced NSCLC | NCT04959981 | Advanced Non-sq... | ERAS-007 ERAS-601 Osimertinib Sotorasib | 18 Years - 99 Years | Erasca, Inc. | |
| A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) | NCT03157128 | Non-Small Cell ... Medullary Thyro... Colon Cancer Any Solid Tumor | LOXO-292 | 12 Years - | Eli Lilly and Company | |
| A Vaccine Trial for Patients With Stage IIIB, IV, or Recurrent Non-Small Cell Lung Cancer | NCT01574222 | Non-Small Cell ... | autologous dend... | 21 Years - | VA Office of Research and Development | |
| Follow-up Modalities of Low Grade Precancerous Bronchial Lesions | NCT00213603 | Precancerous Co... Thoracic Neopla... | 18 Years - 80 Years | University Hospital, Rouen | ||
| Role of Ultrasound Guided Peripheral Thoracic Tumors | NCT04741958 | Thoracic Neopla... | Ultrasound Guid... | - | Beni-Suef University | |
| A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection | NCT03083743 | Non-small-cell ... | Recombinant hum... Placebo | 18 Years - 75 Years | Shanghai Gebaide Biotechnology Co., Ltd. | |
| Sintilimab (IBI308) in the Neoadjuvant Treatment of Patients With Resectable II-IIIA NSCLC | NCT04371796 | Lung Diseases Neoplasms Respiratory Tra... Thoracic Neopla... Non-small-cell ... | Sintilimab inje... | 18 Years - 75 Years | Sichuan Cancer Hospital and Research Institute | |
| A Study of Gemcitabine-Carboplatin Plus Necitumumab (LY3012211) in Chemotherapy-Naïve Participants With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC) | NCT02941601 | Locally Advance... Metastatic Squa... | Necitumumab Gemcitabine Carboplatin | 18 Years - | Eli Lilly and Company | |
| Study of Patritumab in Combination With Erlotinib in Subjects With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC). (HER3-Lung) | NCT02134015 | Lung Cancer Non-small Cell ... | Patritumab Erlotinib Placebo | 20 Years - | Daiichi Sankyo | |
| Effectiveness of an Educational Intervention Aimed at Increasing the Emotional Competencies of Patients Under Surveillance After Antineoplastic Treatment of Oesogastric or Bronchopulmonary Cancer | NCT04556344 | Digestive Syste... Thoracic Neopla... | Emotional skill... Short free talk... | 18 Years - | University Hospital, Lille | |
| Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer | NCT05297734 | End of Life Cancer | Receive technol... Receive redesig... | 21 Years - | Stanford University | |
| A Study to Investigate Efficacy and Safety of Ceralasertib Plus Durvalumab in Participants Aged ≥ 18 Years With Advanced or Metastatic Non-small Cell Lung Cancer Whose Disease Progressed on or After Prior Anti-PD-(L)1 Therapy and Platinum-based Chemotherapy | NCT05941897 | Advanced or Met... | Ceralasertib Durvalumab | 18 Years - | AstraZeneca | |
| Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage I, II and IIIA Non-small Cell Lung Cancer | NCT02904954 | Carcinoma, Non-... | Durvalumab Durvalumab plus... | 18 Years - | Weill Medical College of Cornell University | |
| Identifying Genomic Mutations of Multiple Primary Lung Cancers by Circulating Tumor DNA | NCT02833467 | Carcinoma Non-small-cell ... Thoracic Neopla... | 18 Years - | Peking University People's Hospital | ||
| Phase III Trial to Evaluate the Elortinib vs Gefitinib in Advanced NSCLC With EGFR Exon 19 or 21 Mutations | NCT01024413 | Thoracic Neopla... | erlotinib gefitinib | - | Chinese Society of Lung Cancer | |
| Real World Registry for Use of the Ion Endoluminal System | NCT06004440 | Lung Cancer Multiple Pulmon... Lung Neoplasms Respiratory Tra... Thoracic Neopla... Neoplasms by Si... Neoplasms Lung Diseases Respiratory Tra... | Ion Endoluminal... | 18 Years - | Intuitive Surgical | |
| Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarcomatoid Carcinoma | NCT04725448 | Pulmonary Sarco... Non-small Cell ... Lung Diseases Thoracic Neopla... | Toripalimab Bevacizumab Nab-paclitaxel Carboplatin | 18 Years - 75 Years | Sichuan Cancer Hospital and Research Institute | |
| Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS | NCT05379985 | Non-small Cell ... Colorectal Canc... Pancreatic Duct... Advanced Solid ... | RMC-6236 | 18 Years - | Revolution Medicines, Inc. | |
| A Study of Gemcitabine-Carboplatin Plus Necitumumab (LY3012211) in Chemotherapy-Naïve Participants With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC) | NCT02941601 | Locally Advance... Metastatic Squa... | Necitumumab Gemcitabine Carboplatin | 18 Years - | Eli Lilly and Company | |
| New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy | NCT04564157 | Non-Small Cell ... Adjuvant Chemot... | Carboplatin Paclitaxel Nivolumab | 18 Years - | Fundación GECP | |
| Comparison Between McGrath and Macintosh Laryngoscopes for DLT Intubation in Thoracic Surgery Patients. | NCT05988736 | Thoracic Diseas... Thoracic Neopla... Thoracic Empyem... | MaCintosh Laryn... McGrath Laryngo... | 18 Years - 65 Years | Aga Khan University | |
| A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors | NCT04644315 | Neoplasms Colorectal Neop... Melanoma Pancreatic Neop... Sarcoma Ovarian Neoplas... Brain Neoplasms Thyroid Neoplas... Neuroendocrine ... Cholangiocarcin... Salivary Gland ... Head and Neck N... Thyroid Cancer,... Lymphoma, Large... Neoplasms by Si... Respiratory Tra... Thoracic Neopla... Respiratory Tra... Carcinoma, Bron... Bronchial Neopl... Intestinal Neop... Gastrointestina... Digestive Syste... Digestive Syste... Gastrointestina... Colonic Disease... Intestinal Dise... Central Nervous... | Alectinib | 18 Years - | Hoffmann-La Roche | |
| (SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC | NCT04862780 | Lung Neoplasms Carcinoma, Non-... Respiratory Tra... Neoplasms Neoplasms by Si... Lung Diseases Respiratory Tra... Carcinoma, Bron... Bronchial Neopl... Adenocarcinoma Carcinoma Neoplasms by Hi... Neoplasms, Nerv... EGFR T790M EGFR C797S EGFR L858R EGFR Gene Mutat... EGF-R Positive ... EGFR Exon 19 De... EGFR Mutation R... EGFR Activating... Protein Kinase ... Antineoplastic ... Thoracic Neopla... | BLU-945 osimertinib | 18 Years - | Blueprint Medicines Corporation | |
| New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy | NCT04564157 | Non-Small Cell ... Adjuvant Chemot... | Carboplatin Paclitaxel Nivolumab | 18 Years - | Fundación GECP | |
| Comparison Between McGrath and Macintosh Laryngoscopes for DLT Intubation in Thoracic Surgery Patients. | NCT05988736 | Thoracic Diseas... Thoracic Neopla... Thoracic Empyem... | MaCintosh Laryn... McGrath Laryngo... | 18 Years - 65 Years | Aga Khan University | |
| The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial | NCT03402048 | Stage IV, NSCLC Lung Neoplasms Bronchial Neopl... Carcinoma, Bron... Lung Diseases Neoplasms Respiratory Tra... Respiratory Tra... Thoracic Neopla... | Carboplatin Gemcitabine Pemetrexed Docetaxel Vinorelbine | 70 Years - | University of Turin, Italy | |
| Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors | NCT02909452 | Neoplasms Neoplasms, Glan... Neoplasms by Hi... Bronchial Neopl... Lung Neoplasms Respiratory Tra... Thoracic Neopla... Digestive Syste... Endocrine Gland... Carcinoma, Non-... Lung Diseases Breast Diseases Renal Neoplasm Solid Tumors | Entinostat Pembrolizumab | 18 Years - | Syndax Pharmaceuticals | |
| Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients | NCT00437372 | Cancer Head and Neck C... Pelvic Cancer Nervous System ... Thoracic Neopla... | Sunitinib External Beam R... | 18 Years - | Thomas Jefferson University | |
| A Vaccine Trial for Patients With Stage IIIB, IV, or Recurrent Non-Small Cell Lung Cancer | NCT01574222 | Non-Small Cell ... | autologous dend... | 21 Years - | VA Office of Research and Development | |
| Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients | NCT04512430 | Non Small Cell ... EGFR Gene Mutat... | Atezolizumab Bevacizumab Carboplatin Pemetrexed | 18 Years - | Fundación GECP | |
| Studying a New Piece of Equipment That Can Help Plan Radiation Therapy of the Spine | NCT04227717 | Thoracic Cancer Spine Cancer Thoracic Diseas... Spine Disease Thoracic Neopla... Spine Metastase... | MRI with custom... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| The Effects of a Family-Centered Tai Chi Exercise on Lung Function and Mental Health of Patients After Thoracoscopic Surgery | NCT06104774 | Thoracic Neopla... | Tai Chi Exercis... | 18 Years - | China Medical University Hospital | |
| NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors | NCT04332653 | Any Advanced So... Triple Negative... Non Small Cell ... Small Cell Lung... Microsatellite ... Pancreatic Canc... Ovarian Cancer | NT-I7 pembrolizumab (... | 18 Years - | NeoImmuneTech | |
| mHealth ALIBIRD: A Digital Health Care Model | NCT05770869 | Thoracic Neopla... | ALIBIRD mHealth... | 18 Years - 80 Years | Fundación Investigación E Innovación Biomédica Hospital Universitario Infanta Sofia-Henares | |
| A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements | NCT03093116 | Locally Advance... Metastatic Soli... | Oral repotrecti... | 12 Years - | Turning Point Therapeutics, Inc. | |
| (HARMONY) Study of BLU-701 in EGFR-mutant NSCLC | NCT05153408 | Lung Neoplasm Carcinoma, Non-... Respiratory Tra... Neoplasms Neoplasms by Si... Lung Diseases Respiratory Tra... Carcinoma, Bron... Bronchial Neopl... Adenocarcinoma Carcinoma Neoplasms by Hi... Neoplasms, Nerv... EGFR C797S EGFR C797A EGFR L858R EGFR Exon 19 De... EGFR Gene Mutat... EGF-R Positive ... EGFR Mutation R... EGFR Activating... Thoracic Neopla... Antineoplastic ... Protein Kinase ... EGFR C797G EGFR C797X Non Small Cell ... | BLU-701 osimertinib carboplatin pemetrexed | 18 Years - | Blueprint Medicines Corporation | |
| A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors | NCT03899792 | Medullary Thyro... Infantile Myofi... Infantile Fibro... Papillary Thyro... Soft Tissue Sar... | LOXO-292 | 6 Months - 21 Years | Eli Lilly and Company | |
| Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors | NCT03037385 | RET-altered Non... Medullary Thyro... RET-altered Pap... RET-altered Col... RET-altered Sol... Lung Neoplasm Carcinoma, Non-... Thyroid Disease... Thyroid Neoplas... Thyroid Cancer,... Carcinoma, Neur... Respiratory Tra... Thoracic Neopla... Neoplasms by Si... Neoplasms Lung Diseases Respiratory Tra... Carcinoma, Bron... Bronchial Neopl... Endocrine Syste... Endocrine Gland... Head and Neck N... Adenocarcinoma,... Adenocarcinoma Carcinoma Neoplasms, Glan... Neoplasms by Hi... Neuroendocrine ... Neuroectodermal... Neoplasms, Germ... Neoplasms, Nerv... Colonic Neoplas... Colorectal Neop... Intestinal Neop... Gastrointestina... Digestive Syste... Digestive Syste... Gastrointestina... Colonic Disease... Intestinal Dise... | pralsetinib (BL... | 18 Years - | Hoffmann-La Roche | |
| Monitoring Radiobiological Effects in Thoracic Malignancy by Using Myocardial Perfusion Scan | NCT01913769 | Thoracic Neopla... Late Effect of ... | Thallium-201 My... | 20 Years - 80 Years | Far Eastern Memorial Hospital | |
| A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung Cancer | NCT01039948 | Carcinoma, Non-... Lung Neoplasms Lung Cancer Respiratory Tra... | AV-299 + gefiti... Gefitinib | 18 Years - | AVEO Pharmaceuticals, Inc. | |
| A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors | NCT04644315 | Neoplasms Colorectal Neop... Melanoma Pancreatic Neop... Sarcoma Ovarian Neoplas... Brain Neoplasms Thyroid Neoplas... Neuroendocrine ... Cholangiocarcin... Salivary Gland ... Head and Neck N... Thyroid Cancer,... Lymphoma, Large... Neoplasms by Si... Respiratory Tra... Thoracic Neopla... Respiratory Tra... Carcinoma, Bron... Bronchial Neopl... Intestinal Neop... Gastrointestina... Digestive Syste... Digestive Syste... Gastrointestina... Colonic Disease... Intestinal Dise... Central Nervous... | Alectinib | 18 Years - | Hoffmann-La Roche | |
| Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer Patients | NCT03803787 | Radiation Pneum... | Inhaled budeson... | 18 Years - 75 Years | Instituto Nacional de Cancerologia de Mexico | |
| Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients | NCT00437372 | Cancer Head and Neck C... Pelvic Cancer Nervous System ... Thoracic Neopla... | Sunitinib External Beam R... | 18 Years - | Thomas Jefferson University | |
| Phase III Trial to Evaluate the Elortinib vs Gefitinib in Advanced NSCLC With EGFR Exon 19 or 21 Mutations | NCT01024413 | Thoracic Neopla... | erlotinib gefitinib | - | Chinese Society of Lung Cancer | |
| Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients | NCT00437372 | Cancer Head and Neck C... Pelvic Cancer Nervous System ... Thoracic Neopla... | Sunitinib External Beam R... | 18 Years - | Thomas Jefferson University | |
| A Vaccine Trial for Patients With Stage IIIB, IV, or Recurrent Non-Small Cell Lung Cancer | NCT01574222 | Non-Small Cell ... | autologous dend... | 21 Years - | VA Office of Research and Development | |
| Erector Spinae Block for Thoracic Surgery | NCT05521789 | Pulmonary Neopl... Pulmonary Cance... Thoracic Diseas... Thoracic Cancer Thoracic Neopla... | ESB Thoracic | 18 Years - 90 Years | George Washington University | |
| (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations | NCT05241873 | Lung Neoplasm M... Carcinoma, Non-... Respiratory Tra... Neoplasms Neoplasms by Si... Lung Diseases Respiratory Tra... Carcinoma, Bron... Bronchial Neopl... Adenocarcinoma Carcinoma Neoplasms by Hi... EGFR Exon 20 Mu... EGFR Exon 20 In... EGFR Activating... Antineoplastic ... Metastatic Lung... Brain Metastase... EGFR-mutated NS... EGFR Atypical M... | BLU-451 Carboplatin Pemetrexed | 18 Years - | Blueprint Medicines Corporation | |
| Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy | NCT02984761 | Lung Neoplasm | Stereotactic Ra... Anatomic Pulmon... | 18 Years - | VA Office of Research and Development | |
| Prospective Study on Factors Predicting Chemo-Radiotherapy Induced Pulmonary and Esophageal Injury | NCT00631839 | Thoracic Neopla... | Thoracic 3-D Co... | 18 Years - 75 Years | Shanghai Cancer Hospital, China | |
| Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors | NCT02897778 | Neoplasms Neoplasms, Glan... Neoplasms by Hi... Bronchial Neopl... Lung Neoplasms Respiratory Tra... Thoracic Neopla... Digestive Syste... Endocrine Gland... Carcinoma, Non-... Lung Diseases Breast Neoplasm... Breast Diseases Renal Neoplasm Solid Tumors | Entinostat Placebo | 18 Years - | Syndax Pharmaceuticals | |
| Erector Spinae Block for Thoracic Surgery | NCT05521789 | Pulmonary Neopl... Pulmonary Cance... Thoracic Diseas... Thoracic Cancer Thoracic Neopla... | ESB Thoracic | 18 Years - 90 Years | George Washington University | |
| Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC | NCT04133337 | Lung Diseases Neoplasms Respiratory Tra... Thoracic Neopla... Non-small-cell ... | Apatinib SHR-1210 | 18 Years - 75 Years | Sichuan Cancer Hospital and Research Institute | |
| Pain Control After VATS Anatomical Pulmonary Resections | NCT05993273 | Lung Cancer Pain, Postopera... Thoracic Neopla... | Epidural ESP block Cryoanalgesia | 18 Years - | University Hospital Padova | |
| Radiotherapy Treatments for the Treatment of Thoracic District Tumors | NCT06335290 | Thoracic Neopla... | 18 Years - | European Institute of Oncology | ||
| Erector Spinae Block for Thoracoscopic Surgery | NCT04751552 | Postoperative P... Thoracic Neopla... | Erector Spinae ... | 18 Years - | St. Antonius Hospital | |
| Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC) | NCT01999985 | Lung Cancer Non-small Cell ... | Dasatinib - 1A Afatinib - 1A Dasatinib - 1B Afatinib - 1B | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors | NCT03899792 | Medullary Thyro... Infantile Myofi... Infantile Fibro... Papillary Thyro... Soft Tissue Sar... | LOXO-292 | 6 Months - 21 Years | Eli Lilly and Company | |
| (SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC | NCT04862780 | Lung Neoplasms Carcinoma, Non-... Respiratory Tra... Neoplasms Neoplasms by Si... Lung Diseases Respiratory Tra... Carcinoma, Bron... Bronchial Neopl... Adenocarcinoma Carcinoma Neoplasms by Hi... Neoplasms, Nerv... EGFR T790M EGFR C797S EGFR L858R EGFR Gene Mutat... EGF-R Positive ... EGFR Exon 19 De... EGFR Mutation R... EGFR Activating... Protein Kinase ... Antineoplastic ... Thoracic Neopla... | BLU-945 osimertinib | 18 Years - | Blueprint Medicines Corporation |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
